Abeona Therapeutics, Inc. (ABEO)
4.97
+0.03
(+0.61%)
USD |
NASDAQ |
Mar 04, 16:00
4.97
0.00 (0.00%)
Pre-Market: 08:20
Abeona Therapeutics Cash from Investing (TTM) : 114.35M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 209.07M |
| Plus Therapeutics, Inc. | 0.287M |
| Atossa Therapeutics, Inc. | -0.016M |
| Cell Source, Inc. | 0.00 |
| Kiora Pharmaceuticals, Inc. | 9.560M |